BioEngine was selected as the 2019 Shanghai "NEW SPECIALIZED" Small and Medium-sized Enterprise

The implementation of the "NEW SPECIALIZED" Small and Medium-sized Enterprise cultivation project is an important initiative of the Party Central Committee and the State Council to promote the high-quality development of SMEs, aiming to guide SMEs to take the path of specialization, refinement, specialization, and novelty, and improve their professional development capability, innovation and influence.

The successful selection of BioEngine as one of the 2019 Shanghai "NEW SPECIALIZED" Small and Medium-sized Enterprises shows that BioEngine's technological strength, innovation ability, and management ability have been recognized, and it is at the leading level in its industry in terms of market, quality, efficiency, and development, with advanced and exemplary features.

Over the years, BioEngine has been committed to providing biopharmaceutical companies with high-quality one-stop services from cell culture process development and optimization, culture medium formulation design, and culture medium dry powder processing and manufacturing. In the future, BioEngine will continue to build on its technological advantages, promote product updates and service optimization, and help the progress and development of the biopharmaceutical field.